Iteos Belgium S.A.
Records under this name other than the patents Iteos Belgium S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,427,594 | Non Brain Penetrant A2A Inhibitors and Methods for Use in the Treatment of Cancers Lapsed on the fee record Ended Aug 30, 2026 · High confidence | Lapsed on the fee record | Ended Aug 30, 2026 | High confidence |
| US 11,376,255 | Thiocarbamate Derivatives as A2A Inhibitors, Pharmaceutical Composition Thereof and Combinations with Anticancer Agents Lapsed on the fee record Ended Jul 5, 2026 · High confidence | Lapsed on the fee record | Ended Jul 5, 2026 | High confidence |
| 16/634,506 | Anti-Tigit Antibodies Abandoned Abandoned Dec 5, 2021 | Abandoned | Abandoned Dec 5, 2021 | |
| 16/993,897 | 2-OXO-THIAZOLE Derivatives as A2A Inhibitors and Compounds for Use in the Treatment of Cancers Abandoned Abandoned Oct 3, 2022 | Abandoned | Abandoned Oct 3, 2022 | |
| 17/281,156 | Use of an Inhibitor of an Ent Family Transporter in the Treatment of Cancer and Combination Thereof with an Adenosine Receptor Antagonist Abandoned Abandoned Feb 23, 2026 | Abandoned | Abandoned Feb 23, 2026 | |
| 17/829,919 | Thiocarbamate Derivatives as A2A Inhibitors, Pharmaceutical Composition Thereof and Combinations with Anticancer Agents Abandoned Abandoned Oct 31, 2025 | Abandoned | Abandoned Oct 31, 2025 | |
| 17/867,229 | Non Brain Penetrant A2A Inhibitors and Methods for Use in the Treatment of Cancers Abandoned Abandoned Apr 30, 2025 | Abandoned | Abandoned Apr 30, 2025 | |
| 17/872,494 | Anti-TIGIT Antibodies Abandoned Abandoned Dec 31, 2025 | Abandoned | Abandoned Dec 31, 2025 | |
| 17/895,667 | PYRIMIDO[5,4-d]PYRIMIDINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS Abandoned Abandoned Dec 3, 2025 | Abandoned | Abandoned Dec 3, 2025 | |
| 17/919,115 | Methods and Formulations for Administration of Thiocarbamate Deriviatives A2A Inhibitors Abandoned Abandoned Dec 15, 2025 | Abandoned | Abandoned Dec 15, 2025 |